Severe Acute Respiratory Syndrome Coronavirus 2

Patients with liver diseases, especially those with cirrhosis, have an increased mortality risk when infected by SARS-CoV-2 and therefore anti-SARS-CoV-2 vaccine has been recommended by leading Scientific Associations for all patients with chronic liver diseases. However, previous reports have shown a reduced antibody response following the full course of vaccination in immunosuppressed patients, including liver transplant recipients and several rheumatic diseases.
Effects of the COVID-19 public health crisis related to biodiversity loss and ecosystem health
The ongoing COVID-19 pandemic, caused by zoonotic SARS-CoV-2, has important links to biodiversity loss and ecosystem health. These links range from anthropogenic activities driving zoonotic disease emergence and extend to the pandemic affecting biodiversity conservation, environmental policy, ecosystem services, and multiple conservation facets. Crucially, such effects can exacerbate the initial drivers, resulting in feedback loops that are likely to promote future zoonotic disease outbreaks.

eClinicalMedicine, Volume 37, July 2021

This Research paper supports SDGs 3 and 10 by characterising racial disparities among pregnant women with SARS-CoV-2. The findings showed that Black women were more likely to have occupational exposure to SARS-CoV-2 than White women and that Black women with SARS-CoV-2 during pregnancy were more likely to have a preterm delivery.
This Research paper supports SDGs 3 and 10 by assessing ethnic differences in SARS-CoV-2 seropositivity among hospital workers. The findings showed that Black people had more than double the likelihood of SARS-CoV-2 seropositivity compared with White people, independent of age, sex, socioeconomic factors, and hospital role.
This study supports SDG 3 and 10 by showing increased mortality due to COVID-19 in Brazil’s mixed ethnicity and Black populations and regions with lower levels of socioeconomic development, highlighting the need to better protect these vulnerable groups from the adverse effects of the COVID-19 pandemic.